Drug slows progress of Huntington's Disease

05/21/2004 | BBC

British researchers found in animal tests that rapamycin, currently used to prevent organ rejection in transplant cases, not only slowed the progress of the incurable central nervous system disease but also delays its onset. Researchers said rapamycin works by reducing the amount of the toxic protein causing the disease, raising hopes that more people would be willing to be tested for the inherited disease if there is a drug that can slow its progress.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL